But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders of Omnicell, Inc. (NASDAQ:OMCL); the share price is down a whopping 75% in the ...

Among others, following stocks were impacted: ・Healthcare Technology for Providers company Omnicell (NASDAQ:OMCL) fell 5.4%. Is now the time to buy Omnicell? Access our full analysis report here ...

Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

Omnicell (NASDAQ:OMCL) has had a rough three months with its share price down 21%. We, however decided to study the company's financials to determine if they have got anything to do with the price ...

Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...

Shares of NASDAQ OMCL opened at $34.47 on Monday. Omnicell has a one year low of $25.12 and a one year high of $55.75. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to ...